Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case–control study

• Published in: Breast cancer research and treatment Vol. 111; no. 3; pp. 549 - 553
• Main Authors: Saadat, Mostafa, Kohan, Leila, Omidvari, Shahpour
• Format: Journal Article
• Language: English
• Published: Boston Springer US 01.10.2008; Springer; Springer Nature B.V
• Subjects: Adult; Asian Continental Ancestry Group - genetics; Biological and medical sciences; Breast cancer; Breast Neoplasms - ethnology; Breast Neoplasms - genetics; Cancer research; Case-Control Studies; Codon; DNA-Binding Proteins - genetics; Epidemiology; Female; Gene Frequency; Genes, Recessive; Genetic Predisposition to Disease; Genotype & phenotype; Gynecology. Andrology. Obstetrics; Humans; Iran - epidemiology; Mammary gland diseases; Medical sciences; Medicine; Medicine & Public Health; Middle Aged; Minority & ethnic groups; Odds Ratio; Oncology; Polymorphism; Polymorphism, Genetic; Risk Assessment; Risk Factors; Tumors; X-ray Repair Cross Complementing Protein 1; Iran; Asia; Risk; Breast cancer; Iran; Genetic polymorphism; Human; Breast disease; Genetic variability; Genotype; XRCC1; Malignant tumor; Case control study; Repair gene; Mammary gland diseases; Codon; Risk factor; Adult; Female; Woman; Cancer; Polymorphism
• ISSN: 0167-6806; 1573-7217
• DOI: 10.1007/s10549-007-9811-5

The X-ray repair cross-complementation group 1 (XRCC1) protein plays an important role in base excision repair. In the present study, we specifically investigated whether common genetic variant in XRCC1 (exon 10, codon Arg399Gln ) was associated with an altered risk of breast cancer. The eligible cases were patients at chemotherapy unit of Nemazi hospital, Shiraz Iran, from October 1999 to August 2000 and from July 2004 to July 2005. The present study included 186 females with breast cancer. Age frequency-matched controls were randomly selected from the healthy females blood donor, according to the age distribution of the cases. A total of 187 healthy females included in the study. Using PCR-based method, the XRCC1 Arg399Gln polymorphism was determined. In control group the 399Gln allele frequency was 32.6%. The genotypic frequencies of the control subjects did not show significant deviation from Hardy-Weinberg equilibrium (χ 2  = 1.683, df = 1, P  > 0.05). A statistically significant association was observed in comparison between Gln/Gln and Arg/Arg genotype (OR = 2.01, 95% CI:1.02–3.94, P  = 0.041). There was no linear trend for presence of 0, 1, and 2 of the 399Gln allele and risk of breast cancer (χ 2  = 1.212, P  = 0.271). In the recessive effect of the Gln allele (comparison between Gln/Gln vs. Arg/Arg + Arg/Gln ), Gln/Gln genotype significantly increased the risk of breast cancer (OR = 2.31, 95% CI:1.21–4.35, P  = 0.010). In the dominant effect of the Gln allele (comparison between Gln/Gln + Arg/Gln vs. Arg/Arg ), Gln/Gln + Arg/Gln genotypes was not associated with the risk of breast cancer (OR = 0.95, 95% CI:0.63–1.42, P  = 0.799). It is concluded that 399Gln allele may act as a recessive allele and increase the breast cancer risk.